KDR and glioblastoma: Most studies revealed that VEGFR-2, which is greatly expressed in GBM, is the most active receptor in GBM angiogenesis, mediating the angiogenic, mitogenic, and permeability-enhancing effects of VEGF-A [157,159,162].